Van Andel Institute Discovery Aids Drug Developers
GRAND RAPIDS - Researchers in the Laboratory of Structural Sciences at Van Andel Institute have determined how the parathyroid hormone, which is currently used to treat osteoporosis, precisely binds to its receptor. Drug developers can use this information to aid in the design of more potent therapies for osteoporosis that lack the undesired side effects